Type 2 Diabetes

Notable updates to the American Diabetes Association’s 2023 Standards of Care address the role of weight loss in diabetes management and cardiovascular risks and now advise lower targets for blood pressure and LDL cholesterol.

Long-term use of glimepiride may improve survival and reduce hospitalizations in hospitalized patients with concomitant type 2 diabetes and chronic HF, researchers reported.

Adults with type 2 diabetes who lost at least 10% of their body weight engaged in more physical activity and slept better at 12 and 24 months than those who lost less weight, according to a study published in Diabetic Medicine.

Initiation rates of GLP-1 receptor agonists and SGLT2 inhibitors among older adults with type 2 diabetes and atherosclerotic cardiovascular disease or congestive heart failure remained low from 2016 to 2019, according to study data.

Earlier in the week, I was contacted by Ellen Dran, mother of the late Dr. Sarah Hallberg. For those who may not know her, Sarah was a champion of medicine and of life.

It is more appropriate to use BMI as the determinant for metabolic and bariatric surgery in treatment of type 2 diabetes.

During the past 20 years, Endocrine Today has reported on advancements in bariatric and metabolic surgery, including the evolution of the procedure and growth of high-quality clinical trial data documenting efficacy and safety.

From 2000 to 2019, the prevalence of type 2 diabetes quadrupled, increasing the overall prevalence of pregestational diabetes. The rise in pregestational diabetes increased the odds of adverse pregnancy outcomes, researchers reported.

Researchers found evidence that GLP-1 receptor agonists, but not SGLT2 inhibitors or DPP-IV inhibitors, may help prevent stroke for individuals with type 2 diabetes, according to results of a meta-analysis.

Obesity was not a universal phenotype among children with type 2 diabetes, despite being an important risk factor, according to a systematic review and meta-analysis published in JAMA Network Open.